Zoetis (ZTS) Gains from Investment Securities (2012 - 2026)

Zoetis (ZTS) reported Gains from Investment Securities of $50.0 million for Q1 2026, up 5100.0% year-over-year from $961538.5 in Q1 2025, and down 93.03% quarter-over-quarter from $717.0 million in Q4 2025.

Zoetis (ZTS) Gains from Investment Securities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Gains from Investment Securities data on file, last reported at $50.0 million in Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at $50.0 million, up 5100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $766.0 million (changed N/A YoY), and the FY2025 annual result was $715.0 million, up 35650.0% from the prior year.
  • Gains from Investment Securities fell to $50.0 million in Q1 2026 per ZTS's latest filing, from $717.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $717.0 million in Q4 2025 and troughed at -$479.0 million in Q3 2024.
  • A 5-year average of $47.6 million and a median of $2.0 million in 2023 frame the typical range for Gains from Investment Securities.
  • The sharpest annual moves came in 2023 and 2026: Gains from Investment Securities plunged 9300.0% in 2023, then soared 5100.0% in 2026.
  • A 5-year view of Gains from Investment Securities shows it stood at -$46.0 million in 2022, then jumped by 91.3% to -$4.0 million in 2023, then slumped by 11875.0% to -$479.0 million in 2024, then surged by 249.69% to $717.0 million in 2025, then sank by 93.03% to $50.0 million in 2026.
  • Business Quant data shows ZTS's Gains from Investment Securities at $50.0 million in Q1 2026, $717.0 million in Q4 2025, and -$4.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.00 Mn
Mar 31, 2026 50.00 Mn
Dec 31, 2025 717.00 Mn
Dec 31, 2025 717.00 Mn
Sep 30, 2025 -4.00 Mn
Sep 30, 2025 -4.00 Mn
Jun 30, 2025 3.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 -1.00 Mn
Mar 31, 2025 -1.00 Mn
Sep 30, 2024 -479.00 Mn
Sep 30, 2024 -479.00 Mn
Jun 30, 2024 480.00 Mn
Jun 30, 2024 480.00 Mn
Mar 31, 2024 1.00 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 -4.00 Mn
Dec 31, 2023 -4.00 Mn
Sep 30, 2023 -460.00 Mn
Sep 30, 2023 -460.00 Mn